Gliflozin

SGLT2 inhibitor

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Gliflozin, covering 2021-03-12 to 2026-02-06. Get the full timeline:

Most recent: Clinical Trial Update: Early Gliflozin for Elderly Patients With Acute Decompensated Heart Failure in the Emergency Department [NA]